Access Bio

Access Bio develops and manufactures rapid diagnostic test kits, portable devices that detect diseases or health conditions from a blood, urine, or saliva sample without sending it to a laboratory.

Its products serve the point-of-care testing market, meaning clinics, pharmacies, or field settings where a fast result is needed on the spot. The company draws on three core technologies, immunochemical diagnostics, biosensors, and molecular diagnostics, and its diagnostic reagents are regulated as pharmaceutical products under Korean manufacturing standards. It is listed on KOSDAQ, South Korea's tech-focused small-cap exchange.